The person sought medical attention with general weakness, fever and rash. She is currently under medical supervision, according to the protocols in force, and her condition is satisfactory. ANSP specialists have initiated the epidemiological investigation and are applying the necessary measures to prevent and control the infection.
The last two cases of infection with this virus in the Republic of Moldova were recorded in 2022, both of which were also imported cases.
According to the data provided by European Center for Disease Prevention and Control (ECDC), in the last two years, cases of MPXV infection have been reported in several European countries. In December 2025 and January 2026, illnesses were reported in Romania and Czechia.
ANSP reminds that the infection is caused by the monkeypox virus, present in wildlife in several countries in Central and West Africa. The virus is not endemic in Europe, with only imported cases being reported.
Monkey pox is not easily transmitted from person to person, requiring close contact. The virus enters the body through broken skin, the respiratory tract, eyes, nose or mouth, as well as through contact with infected body fluids. Transmission occurs mainly through close and prolonged physical contact with an infected person or through contact with contaminated objects.
Clinical manifestations include fever, headache, chills, weakness, swollen lymph nodes, skin rashes, mucosal lesions, and muscle and back pain.
Currently, there is a vaccine against the infection, especially recommended in areas with active transmission. To reduce the risk of illness, the ANSP recommends observing hygiene measures, avoiding close contact with suspected or confirmed persons, avoiding contact with wild animals in the affected areas and contacting a doctor in the event of the appearance of suggestive symptoms.
